Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2024 inter alia to consider and approve This is to inform you that meeting of Board of Directors of the Company is scheduled to be held on Thursday October 24 2024 to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30 2024 amongst other matters. Further as per provisions of the Companys Code of Conduct for Prohibition of Insider Trading trading window for Designated Persons of the Company is closed from October 1 2024 and shall open after 48 hrs post declaration of financial results by the Company. The above information will also be available on the website of the Company at www.strides.com. This is for your kind information and record purposes.